Get started
Work

PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative disease

Year: 2003
Type: article
Source: Cancer Cell
DOI: 10.1016/s1535-6108(03)00108-9
Authors: Jan Cools, Elizabeth H Stover, Christina L Boulton, Jason Gotlib, Robert D Legare, Sonia M Amaral, David P Curley, Nicole Duclos, Rebecca Rowan, Jeffery L Kutok, Benjamin H Lee, Ifor R Williams, Steven E Coutre, Richard M Stone, Daniel J DeAngelo, Peter Marynen, Paul W Manley, Thomas Meyer, Doriano Fabbro, Donna Neuberg, Ellen Weisberg, James D Griffin, D.Gary Gilliland
Institutions: Brigham and Women's Hospital, Harvard University, Vlaams Instituut voor Biotechnologie, Howard Hughes Medical Institute, Stanford Medicine, Stanford University, Brown University, Westerly Hospital, Emory University, Dana-Farber Cancer Institute, Novartis (Switzerland)
Language: English
Subfield: Rheumatology
Field: Medicine
Open Access status: bronze
Funders: Leukemia and Lymphoma Society, Vlaamse regering, National Institutes of Health, National Cancer Institute, National Institute of General Medical Sciences, National Institute of Diabetes and Digestive and Kidney Diseases
Awards: G229846313, G2852253759, G409126305, Abnormalities/Signal Transduction/Hematopoietic Disease, G707340384, Development of Novel Therapeutic Strategies in Human Leukemias
OpenAlex ID: W2075428599
FWCI: 14.37
Cites: 46
Cited by: 216
Related to: 10